CORESTA Congress, Shanghai, 2008, SSPT 08
Cancer risk calculations for mainstream smoke constituents from selected cigarette brands: concordance between calculated and observed risk
R.J. Reynolds Tobacco Company, R&D, Winston-Salem, NC, USA
A quantitative cancer risk assessment of mainstream smoke (MSS) constituents was performed for thirty-five (35) U.S. commercial cigarette brands. Products represented a broad range of "tar" yields (0.9 to 19 mg) as determined by machine smoking using...